Funding
Turn ideas into impact
Show Me
Due: September 25, 2028
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-27-026
Due: September 25, 2028
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-444
Due: September 28, 2028
Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-OD-25-010
Due: October 2, 2028
New
Limited Competition: NIGMS Mature Synchrotron Resources (MSR) for Structural Biology (P30 – Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-27-068
Due: October 6, 2028
BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)
Type
Cooperative Agreement
Source
Federal
Opp Number
RFA-NS-27-001
Due: October 20, 2028
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)
US $200,000
Type
Grant
Source
Federal
Opp Number
RFA-HD-27-007
Due: October 26, 2028
Occupational Safety and Health Education and Research Centers (T42)
US $4,500,000 – $9,000,000
Type
Grant
Source
Federal
Opp Number
RFA-OH-25-002
Due: November 2, 2028
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-27-013
Due: November 2, 2028
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-27-012
Do you have a grant, incentive, funding competition, or other funding source to share?